ISPE Announces European Partnerships to Broaden Training Footprint

Share Article

Collaborative initiatives unite expertise from three esteemed organizations

ISPE continuously strives to support our members and industry in staying ahead of the curve on various technical and operational solutions for pharmaceutical and biopharmaceutical manufacturing.

The International Society for Pharmaceutical Engineering (ISPE) announced training partnerships with the Institute of Technology Management at the University of St. Gallen (ITEM–HSG), in St. Gallen, Switzerland, and the National Institute of Bioprocessing Research and Training (NIBRT), in Dublin, Ireland. Joining Tampa, Florida as brick-and-mortar training locales, these collaborative initiatives unite expertise from three esteemed organizations.

“ISPE continuously strives to support our members and industry in staying ahead of the curve on various technical and operational solutions for pharmaceutical and biopharmaceutical manufacturing,” said John Bournas, ISPE CEO and President. “Our partnerships with ITEM-HSG and NIBRT further support our mission by providing ISPE members with a European learning base that leverages innovative training from prominent organizations.”

ISPE training courses will launch in May 2017 at the ITEM–HSG and NIBRT locations. This world-class education will provide heightened training and research solutions in two areas − operational management and commissioning and qualification. Participants will receive two days of topic-specific, in-depth learning, and skill building. Training includes lectures, group exercises, and case studies that provide participants with practical information they can apply immediately to their job. The courses are suited for development, manufacturing, engineering, quality, and validation professionals.

For details on ISPE’s full course offerings, please visit http://www.ispe.org/training.

About ISPE
The International Society for Pharmaceutical Engineering is the world’s largest not-for-profit association serving its members through leading scientific, technical, and regulatory advancement across the entire pharmaceutical lifecycle. The 20,000 members of ISPE are building solutions in the development and manufacture of safe, effective pharmaceutical and biologic medicines and medical delivery devices in more than 90 countries around the world. Founded in 1980, ISPE has its worldwide headquarters in Bethesda, Maryland, USA, and an operations and training center in Tampa, Florida, USA. Visit http://www.ISPE.org for more information.

For more information, contact:
Maria Robertson
Senior Director, Marketing Communications, ISPE
Tel: +1-301-964-9207
Email: mrobertson(at)ispe(dot)org
http://www.ISPE.org

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Maria Robertson
ISPE
+1 813-960-2105 Ext: 404
Email >
Visit website